BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35406411)

  • 1. Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma.
    Ding J; Cui XG; Chen HJ; Sun Y; Yu WW; Luo J; Xiao GQ; Chang C; Qi J; Yeh S
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-SERB promotes vasculogenic mimicry (VM) formation and tumor metastasis in renal cell carcinoma.
    Tang S; Chen F; Zhang J; Chang F; Lv Z; Li K; Li S; Hu Y; Yeh S
    J Biol Chem; 2024 May; 300(5):107297. PubMed ID: 38641065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling.
    He M; Yang H; Shi H; Hu Y; Chang C; Liu S; Yeh S
    Cancer Lett; 2022 Jan; 524():15-28. PubMed ID: 34461182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin Inhibits Vasculogenic Mimicry Via Regulating ETS-1 in Renal Cell Carcinoma.
    Chong Y; Xu S; Liu T; Guo P; Wang X; He D; Zhu G
    Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38299401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC.
    Gu J; Zhang Y; Han Z; Gao L; Cui J; Sun Y; Niu Y; You B; Huang CP; Chang C; Wang X; Yeh S
    Cell Death Dis; 2020 May; 11(5):367. PubMed ID: 32409702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel definition of microvessel density in renal cell carcinoma: Angiogenesis plus vasculogenic mimicry.
    Wu Y; Du K; Guan W; Wu D; Tang H; Wang N; Qi J; Gu Z; Yang J; Ding J
    Oncol Lett; 2020 Nov; 20(5):192. PubMed ID: 32952661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
    Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
    Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
    Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
    Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.
    Song W; He D; Chen Y; Yeh CR; Hsu I; Huang Q; Zhang X; Chang LS; Zuo L; Chen J; Doersch KM; Chang C; Li L; Yeh S
    Mol Oncol; 2018 Dec; 12(12):2055-2071. PubMed ID: 30171816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals.
    Bai J; Yeh S; Qiu X; Hu L; Zeng J; Cai Y; Zuo L; Li G; Yang G; Chang C
    Oncogene; 2018 Nov; 37(44):5901-5912. PubMed ID: 29973687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
    Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
    Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERβ-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma.
    Han Z; Zhang Y; Sun Y; Chen J; Chang C; Wang X; Yeh S
    Cancer Res; 2018 May; 78(10):2550-2563. PubMed ID: 29490945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
    Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
    J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
    Liu W; Lv C; Zhang B; Zhou Q; Cao Z
    RNA; 2017 Jul; 23(7):1019-1027. PubMed ID: 28396577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
    Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
    Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
    Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
    PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
    Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
    Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
    Chen J; Chen S; Zhuo L; Zhu Y; Zheng H
    Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
    Han H; Du L; Cao Z; Zhang B; Zhou Q
    Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.